Results 121 to 130 of about 46,872 (345)

Longitudinal circulating tumor DNA profiling in patients with advanced endometrial cancer using an off‐the‐shelf targeted NGS panel

Molecular Oncology, EarlyView.
Intratumour heterogeneity complicates precision management of advanced endometrial cancer. Circulating tumor DNA (ctDNA) offers a minimally invasive strategy to capture tumor evolution and therapeutic resistance. Here, we compare tumor‐agnostic NGS with tumor‐informed ddPCR, outlining their relative sensitivity, concordance, and clinical implications ...
Carlos Casas‐Arozamena, Karin Teien Lande, Eva Diaz, Ana Vilar, Juan Cueva, Efigenia Arias, Victoria Sampayo, Alicia Abalo, Nerea González, Eva Colás, Antonio Gil‐Moreno, Miguel Abal, Gema Moreno‐Bueno, Therese Sørlie, Kristina Lindemann, Laura Muinelo‐Romay   +15 more
wiley   +1 more source

Comportamiento de la osteoartritis de la rodilla en un grupo de pacientes venezolanos

Archivo Médico de Camagüey, 2011
Fundamento: las enfermedades degenerativas articulares constituyen una causa importante de dolor y pérdida de la función, entre ellas la articulación de la rodilla es una de las más afectadas.
Alejandro Álvarez López, Yenima García Lorenzo, Antonio Puentes Álvarez, Guadalupe López Lastre, Mercedes López Lastre   +4 more
doaj  

[ARE WE READY TO FORGET EVERYTHING WE HAVE LEARNED DURING THE PANDEMIC?] [PDF]

Enferm Intensiva, 2022
Hernández Ortiz JÁ.
europepmc   +1 more source

Impacto del agua de lastre en la salud de trabajadores de embarcaciones de transporte marítimo que navegan en aguas peruanas

, 2022
Miguel Ángel Fernández García
openalex   +2 more sources

Molecular cancer prevention: Intercepting disease

Molecular Oncology, EarlyView.
Oncological practice must evolve, from treating established tumours to proactive cancer interception before clinical manifestation. This will require mechanistic insight into tumour initiation, validated biomarkers of early disease development and redesigned clinical trials, enabling cancer interception to become a core pillar of oncology with the ...
Charlotte Grieco, Tej Pandya, Charles Swanton   +2 more
wiley   +1 more source

Lithium salts as a treatment for COVID-19: Pre-clinical outcomes. [PDF]

Biomed Pharmacother, 2022
Soriano-Torres O, Noa Romero E, González Sosa NL, Enríquez Puertas JM, Fragas Quintero A, García Montero M, Martín Alfonso D, Infante Hernández Y, Lastre M, Rodríguez-Pérez L, Borrego Y, González VE, Vega IG, Ramos Pupo R, Reyes LM, Zumeta Dubé MT, Hernández A, García de la Rosa I, Minguez Suárez A, Alarcón Camejo LA, Rodríguez M, Oliva Hernández R, Rudd CE, Pérez O.   +23 more
europepmc   +1 more source

L’Aula magna dell’Università [PDF]

, 2010
1Opera di Raffaello Fagnoni e Umberto Nordio l'Edificio Centrale dell'Università di Trieste costituisce un significativo esempio dell'architettura italiana della seconda metà anni Trenta.
Barillari, Diana
core   +1 more source

Circulating tumor cell viability during and after radiotherapy mirrors treatment response in cancer patients

Molecular Oncology, EarlyView.
Radiotherapy (RT) response depends on the DNA repair capacity of tumor and host cells. We show that circulating tumor cell (CTC) counts and apoptosis rates before and after RT predict treatment response and outcome, which can be accessed via easily accessible liquid biopsy approaches. Created in BioRender. Wikman, H.
Yvonne Goy, Jana Löptien, Cornelia Coith, Afroditi Nanou, Katharina Hintelmann, Pinnschmidt Hans, Cordula Petersen, Klaus Pantel, Sabine Riethdorf, Kerstin Borgmann, Harriet Wikman   +10 more
wiley   +1 more source

La negociación del conflicto armado interno en Colombia: Dos escenarios probables y otro, posible pero improbable

Sociedad y Economía, 2004
En Colombia con frecuencia se pasa por alto que la historia de fracasos y éxitos parciales obtenidos en procesos de negociación política con grupos irregulares resulta un lastre significativo para cada nuevo proceso que se emprende. La desatención a este
Bernardo Pérez Salazar
doaj  

Immunogenicity and safety assessment of a SARS-CoV-2 recombinant spike RBD protein vaccine (Abdala) in paediatric ages 3-18 years old: a double-blinded, multicentre, randomised, phase 1/2 clinical trial (ISMAELILLO study). [PDF]

EClinicalMedicine, 2023
Cinza-Estévez Z, Resik-Aguirre S, Figueroa-Baile NL, Oquendo-Martínez R, Campa-Legrá I, Tejeda-Fuentes A, Rivero-Caballero M, González-García G, Chávez-Chong CO, Alonso-Valdés M, Hernández-Bernal F, Lemos-Pérez G, Campal-Espinosa A, Freyre-Corrales G, Benítez-Gordillo D, Gato-Orozco E, Pérez Bartutis GS, Mesa-Pedroso I, Bueno-Alemani N, Infante-Aguilar E, Rodríguez Reinoso JL, Melo-Suarez G, Limonta-Fernández M, Ayala-Ávila M, Muzio-González VL, ISMAELILLO Clinical Trial Group.   +25 more
europepmc   +1 more source